RATIONALE AND OBJECTIVES: The anatomic and metabolic changes in human brain tumors treated by radiation therapy were compared using gadolinium-enhanced magnetic resonance imaging and hydrogen (1H) magnetic resonance spectroscopy. The study was intended to assess the potential of 1H magnetic resonance spectroscopy in monitoring response to therapy. METHODS: Thirteen cases of brain cancer treated by radiation therapy were examined by 1H magnetic resonance spectroscopy and gadolinium-enhanced T1-weighted magnetic resonance imaging and reexamined at 2-month intervals. RESULTS: Follow-up after radiation therapy showed changes in post-gadolinium magnetic resonance imaging contrast that are inversely correlated with the changes in choline level (r = -0.69, P < 0.00001) and in tumor volume (r = -0.35, P < 0.05). CONCLUSIONS: The choline loss in tumors gaining post-gadolinium magnetic resonance imaging contrast after therapy is unexpected in view of previously reported correlation between the two in untreated metastatic brain tumors. Indicated is the use of 1H magnetic resonance spectroscopy to discriminate enhancing brain tumors with a high content of vital tumor cells (high choline) from tumors, combining decreased cell density with increased interstitial space (low choline).
RATIONALE AND OBJECTIVES: The anatomic and metabolic changes in humanbrain tumors treated by radiation therapy were compared using gadolinium-enhanced magnetic resonance imaging and hydrogen (1H) magnetic resonance spectroscopy. The study was intended to assess the potential of 1H magnetic resonance spectroscopy in monitoring response to therapy. METHODS: Thirteen cases of brain cancer treated by radiation therapy were examined by 1H magnetic resonance spectroscopy and gadolinium-enhanced T1-weighted magnetic resonance imaging and reexamined at 2-month intervals. RESULTS: Follow-up after radiation therapy showed changes in post-gadolinium magnetic resonance imaging contrast that are inversely correlated with the changes in choline level (r = -0.69, P < 0.00001) and in tumor volume (r = -0.35, P < 0.05). CONCLUSIONS: The choline loss in tumors gaining post-gadolinium magnetic resonance imaging contrast after therapy is unexpected in view of previously reported correlation between the two in untreated metastatic brain tumors. Indicated is the use of 1H magnetic resonance spectroscopy to discriminate enhancing brain tumors with a high content of vital tumor cells (high choline) from tumors, combining decreased cell density with increased interstitial space (low choline).
Authors: Casilda Balmaceda; Dana Critchell; Xiangling Mao; Kenneth Cheung; Susan Pannullo; Robert L DeLaPaz; Dikoma C Shungu Journal: J Neurooncol Date: 2006-01 Impact factor: 4.130
Authors: A Aria Tzika; Maria K Zarifi; Liliana Goumnerova; Loukas G Astrakas; David Zurakowski; Tina Young-Poussaint; Douglas C Anthony; R Michael Scott; Peter McL Black Journal: AJNR Am J Neuroradiol Date: 2002-02 Impact factor: 3.825
Authors: E E Graves; S J Nelson; D B Vigneron; L Verhey; M McDermott; D Larson; S Chang; M D Prados; W P Dillon Journal: AJNR Am J Neuroradiol Date: 2001-04 Impact factor: 3.825
Authors: C Dowling; A W Bollen; S M Noworolski; M W McDermott; N M Barbaro; M R Day; R G Henry; S M Chang; W P Dillon; S J Nelson; D B Vigneron Journal: AJNR Am J Neuroradiol Date: 2001-04 Impact factor: 3.825
Authors: R K Gupta; T F Cloughesy; U Sinha; J Garakian; J Lazareff; G Rubino; L Rubino; D P Becker; H V Vinters; J R Alger Journal: J Neurooncol Date: 2000-12 Impact factor: 4.130
Authors: Heisoog Kim; Ciprian Catana; Eva-Maria Ratai; Ovidiu C Andronesi; Dominique L Jennings; Tracy T Batchelor; Rakesh K Jain; A Gregory Sorensen Journal: Cancer Res Date: 2011-04-20 Impact factor: 12.701
Authors: Torill E Sjøbakk; Roar Johansen; Tone F Bathen; Ursula Sonnewald; Kjell A Kvistad; Steinar Lundgren; Ingrid S Gribbestad Journal: BMC Cancer Date: 2007-07-27 Impact factor: 4.430